Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07340281 · ClinicalTrials.gov registry record · NA
Biomarkers for Exercise
A NA study, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT07340281 is a NA study that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 30 participants.
The verdict
NCT07340281, a NA study, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The overarching objective is to examine the brain-based biological mechanistic pathway by which exercise exerts anxiolytic effects. The investigators will measure brain-derived markers of mitochondrial metabolism (acetyl-L-carnitine \[LAC\]) and inflammation (interleukin-6 \[IL-6\]) using innovative technology to isolate neuronal exosomes.
Interventions
- BEHAVIORAL Exercise Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-03-06 |
| Est. Completion | 2028-01-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07340281
The ClinicalTrials.gov registry entry for NCT07340281 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Exercise Intervention is the first listed.
NCT07340281 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07340281 about?
NCT07340281 is a clinical study titled "Biomarkers for Exercise". The overarching objective is to examine the brain-based biological mechanistic pathway by which exercise exerts anxiolytic effects. The investigators will measure brain-derived markers of mitochondrial metabolism (acetyl-L-carnitine \[LAC\]) and inflammation (interleukin-6 \[IL-6\]) using innovative...
What is the current status of trial NCT07340281?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-03-06. Estimated completion is 2028-01-15.
What interventions are being tested in trial NCT07340281?
The interventions under investigation include: Exercise Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT07340281?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.